[Symptoms and survival in lung cancer (author's transl)]

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.

The Journal of antimicrobial chemotherapy·2016

Cyfra 21-1 - a new tumor-marker for lung-cancer.

Oncology reports·2011

Intraperitoneal hyperthermic perfusion (IPHP).

Oncology reports·2011

Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer.

Oncology reports·2011

TNF-alpha and doxorubicin in hyperthermic perfusion for limb sarcomas.

Oncology reports·2011

Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanoma.

International journal of oncology·2011

Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

Tumori·2026

Survival of carcinoid lung neuroendocrine tumours after surgical resection: A retrospective audit of 633 cases over 26 years.

Tumori·2026

Analysing workflows in radiation oncology: A process mining approach to identify treatment process challenges.

Tumori·2026

A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.

Tumori·2026

When biological complexity demands more than better trial designs.

Tumori·2026

Chimeric thoracodorsal free flap reconstruction for extended circumferential pharyngo-laryngectomy: A case report.

Tumori·2026

Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

Acta oncologica (Stockholm, Sweden)·2026

Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Immunology·2026

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

Journal of the National Cancer Institute·2026

Real-world treatment landscape and clinical outcomes in first-line advanced or metastatic gastroesophageal adenocarcinoma in the United States.

The oncologist·2026

Integrative multi-omics profiling of insomnia-related molecular features reveals microbiome, immune, and therapy-relevant heterogeneity in colorectal cancer.

Microbiology spectrum·2026

Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

Revista espanola de enfermedades digestivas·2026

Related Experiment Videos

[Symptoms and survival in lung cancer (author's transl)]

Related Concept Videos

Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.

Cyfra 21-1 - a new tumor-marker for lung-cancer.

Intraperitoneal hyperthermic perfusion (IPHP).

Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer.

TNF-alpha and doxorubicin in hyperthermic perfusion for limb sarcomas.

Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanoma.

Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

Survival of carcinoid lung neuroendocrine tumours after surgical resection: A retrospective audit of 633 cases over 26 years.

Analysing workflows in radiation oncology: A process mining approach to identify treatment process challenges.

A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.

When biological complexity demands more than better trial designs.

Chimeric thoracodorsal free flap reconstruction for extended circumferential pharyngo-laryngectomy: A case report.

Pre-operative circulating tumour DNA in high-risk primary cutaneous melanoma: prospective feasibility in molecular pathology.

Prognostic Associations of BMI and Metabolic Syndrome With Outcomes After Anti-PD-1 Therapy in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Integrating genetic predictors into subsequent breast cancer risk prediction in survivors of childhood cancer.

Real-world treatment landscape and clinical outcomes in first-line advanced or metastatic gastroesophageal adenocarcinoma in the United States.

Integrative multi-omics profiling of insomnia-related molecular features reveals microbiome, immune, and therapy-relevant heterogeneity in colorectal cancer.

Predicting pancreatic cancer in high-risk individuals and in the general population: how long is the road yet?

Related Experiment Videos

[Symptoms and survival in lung cancer (author's transl)]

Related Concept Videos

Related Articles